BG23001A3 - - Google Patents

Info

Publication number
BG23001A3
BG23001A3 BG26268A BG2626873A BG23001A3 BG 23001 A3 BG23001 A3 BG 23001A3 BG 26268 A BG26268 A BG 26268A BG 2626873 A BG2626873 A BG 2626873A BG 23001 A3 BG23001 A3 BG 23001A3
Authority
BG
Bulgaria
Application number
BG26268A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG23001(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BG23001A3 publication Critical patent/BG23001A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
BG26268A 1972-04-12 1973-04-11 BG23001A3 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
BG23001A3 true BG23001A3 (sv) 1977-05-20

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
BG26268A BG23001A3 (sv) 1972-04-12 1973-04-11

Country Status (31)

Country Link
JP (2) JPS5825656B2 (sv)
KR (1) KR790000113B1 (sv)
AR (1) AR203822A1 (sv)
AT (1) AT323719B (sv)
AU (1) AU472734B2 (sv)
BE (1) BE798051A (sv)
BG (1) BG23001A3 (sv)
CA (1) CA1018188A (sv)
CH (2) CH580563A5 (sv)
CS (2) CS190448B2 (sv)
CY (1) CY963A (sv)
DD (1) DD107670B3 (sv)
DE (1) DE2317710C2 (sv)
DK (1) DK142750C (sv)
ES (1) ES413639A1 (sv)
FR (1) FR2182947B1 (sv)
GB (1) GB1392674A (sv)
HK (1) HK50178A (sv)
HU (2) HU167597B (sv)
IE (1) IE37511B1 (sv)
IL (1) IL42016A (sv)
KE (1) KE2870A (sv)
MY (1) MY7800381A (sv)
NL (1) NL174459C (sv)
PH (1) PH11041A (sv)
PL (2) PL94207B1 (sv)
RO (2) RO65105A (sv)
SE (1) SE399064B (sv)
SU (1) SU496719A3 (sv)
YU (2) YU36483B (sv)
ZA (1) ZA732136B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (sv) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ES8702355A1 (es) * 1981-07-22 1985-07-01 Syntex Inc Procedimiento para la preparacion de antidepresivos reguladores del sistema cardiovascular a base de pirrolidina sustituida
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (sv) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
US7642290B2 (en) 2002-10-03 2010-01-05 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
EP1750691B1 (en) 2004-03-26 2016-08-10 Novaremed Ltd. Compounds for treatment of aids and other diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
AU2010278711A1 (en) 2009-07-31 2012-02-23 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
CA2846604A1 (en) * 2011-08-25 2013-02-28 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
ES2915833T3 (es) 2014-01-31 2022-06-27 Cognition Therapeutics Inc Composiciones de isoindolina y métodos para tratar una enfermedad neurodegenerativa y una degeneración macular
EP3634394A4 (en) 2017-05-15 2021-04-07 Cognition Therapeutics, Inc. COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
YU321279A (en) 1983-04-27
BE798051A (fr) 1973-10-11
PL90695B1 (sv) 1977-01-31
MY7800381A (en) 1978-12-31
JPS58131945A (ja) 1983-08-06
AR203822A1 (es) 1975-10-31
CS190448B2 (en) 1979-05-31
RO70892A (ro) 1982-02-26
JPS6221343B2 (sv) 1987-05-12
PH11041A (en) 1977-10-25
NL7305097A (sv) 1973-10-16
KR790000113B1 (en) 1979-03-20
RO65105A (ro) 1980-01-15
HU166213B (sv) 1975-02-28
DK142750C (da) 1981-08-17
NL174459B (nl) 1984-01-16
CY963A (en) 1978-12-22
AT323719B (de) 1975-07-25
DE2317710A1 (de) 1973-10-18
DD107670A5 (de) 1974-08-12
ZA732136B (en) 1974-03-27
GB1392674A (en) 1975-04-30
KE2870A (en) 1978-09-01
DK142750B (da) 1981-01-12
CH580563A5 (sv) 1976-10-15
YU97673A (en) 1982-02-25
AU5438573A (en) 1974-10-17
JPS497237A (sv) 1974-01-22
DE2317710C2 (de) 1983-08-04
CS190406B2 (en) 1979-05-31
AU472734B2 (en) 1976-06-03
CH569691A5 (sv) 1975-11-28
YU37113B (en) 1984-08-31
YU36483B (en) 1984-02-29
FR2182947B1 (sv) 1976-07-02
SU496719A3 (ru) 1975-12-25
FR2182947A1 (sv) 1973-12-14
IE37511B1 (en) 1977-08-03
JPS5825656B2 (ja) 1983-05-28
HU167597B (sv) 1975-11-28
HK50178A (en) 1978-09-15
NL174459C (nl) 1984-06-18
IL42016A0 (en) 1973-06-29
DD107670B3 (de) 1988-04-06
IL42016A (en) 1976-05-31
ES413639A1 (es) 1976-01-16
PL94207B1 (sv) 1977-07-30
SE399064B (sv) 1978-01-30
CA1018188A (en) 1977-09-27

Similar Documents

Publication Publication Date Title
FR2182947B1 (sv)
JPS4879645A (sv)
FI53251C (sv)
JPS515669B2 (sv)
JPS48109933U (sv)
BG25981A3 (sv)
CH577500A5 (sv)
CH566437A (sv)
CH565494A5 (sv)
CH562124A5 (sv)
CH577269A5 (sv)
CH576696A5 (sv)
CH561414A5 (sv)
CH560333A5 (sv)
CH554968A (sv)
CH380973A4 (sv)
CH576491A5 (sv)
CH574913A5 (sv)
CH577870A5 (sv)
CH567054A5 (sv)
BG21392A3 (sv)
BG21223A3 (sv)
BG21095A1 (sv)
BG20609A3 (sv)
CH566910A5 (sv)